These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 3108431

  • 1. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 3. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan 22; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

  • 4. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
    Anglés-Cano E, Boutière B, Arnoux D, Masson C, Contant G, Benchimol P, Sampol J.
    Thromb Haemost; 1987 Oct 28; 58(3):843-9. PubMed ID: 3124285
    [Abstract] [Full Text] [Related]

  • 5. Diurnal variation of the fibrinolytic system.
    Grimaudo V, Hauert J, Bachmann F, Kruithof EK.
    Thromb Haemost; 1988 Jun 16; 59(3):495-9. PubMed ID: 3142085
    [Abstract] [Full Text] [Related]

  • 6. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F.
    Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812
    [Abstract] [Full Text] [Related]

  • 7. A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease.
    Philips M, Juul AG, Selmer J, Lind B, Thorsen S.
    Thromb Haemost; 1992 Nov 10; 68(5):486-94. PubMed ID: 1455392
    [Abstract] [Full Text] [Related]

  • 8. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activation.
    Petersen LC, Handest P, Brender J, Selmer J, Jørgensen M, Thorsen S.
    Thromb Haemost; 1987 Apr 07; 57(2):205-11. PubMed ID: 3110997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M, Mavri A.
    Thromb Haemost; 1995 Mar 07; 73(3):453-7. PubMed ID: 7667828
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function.
    Wojta J, Binder BR, Huber K, Hoover RL.
    Thromb Haemost; 1989 Apr 25; 61(2):289-93. PubMed ID: 2501899
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
    Urano T, Sumiyoshi K, Pietraszek MH, Takada Y, Takada A.
    Thromb Haemost; 1991 Oct 01; 66(4):474-8. PubMed ID: 1796399
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS.
    Thromb Haemost; 1991 Nov 01; 66(5):581-5. PubMed ID: 1803623
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.
    Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090
    [Abstract] [Full Text] [Related]

  • 19. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C, Angles-Cano E.
    Ann Biol Clin (Paris); 1989 Aug 30; 47(5):269-74. PubMed ID: 2500878
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.